Capricor Therapeutics (CAPR)

Capricor Therapeutics (CAPR) Cash flow


Capricor Therapeutics Cash Flow

CAPR's free cash flow for Q1 2023 was $3.86M. For the 2023 fiscal year, CAPR's free cash flow was decreased by $20.92M and operating cash flow was $4.21M. See a summary of the company’s cash flow.
Cash Flow
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -14.92M$ 4.92M$ -16.81M$ -10.05M$ -6.82M$ -13.86M
Investing Cash Flow
$ -37.66M$ -35.07M$ -1.20M$ 5.44M$ -3.00M$ 4.67M
Financing Cash Flow
$ 4.85M$ 4.87M$ 20.23M$ 33.38M$ 9.18M$ 6.85M
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
$ 43.55M$ 9.60M$ 34.89M$ 32.67M$ 3.90M$ 4.55M
Income Tax Paid Supplemental Data
--$ 0.00$ 0.00$ 0.00$ 0.00
Interest Paid Supplemental Data
--$ 0.00$ 0.00$ 0.00$ 0.00
Issuance Of Capital Stock
$ 4.80M$ 4.80M$ 20.17M$ 27.34M$ 9.17M$ 6.71M
Issuance Of Debt
--$ 0.00$ 318.16K$ 0.00$ 0.00
Repayment Of Debt
Free Cash Flow
$ -17.47M$ 2.92M$ -18.01M$ -10.60M$ -6.82M$ -14.18M
Domestic Sales
Foreign Sales
Currency in USD

Capricor Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis